Axa S.A. Novo Cure LTD Transaction History

Axa S.A.

  • $32.3 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Feb 14, 2023
BUY
$56.6 - $89.9 $5,433 - $8,630
96 Added 0.94%
10,296 $715,000
Q2 2022

Aug 15, 2022
BUY
$56.6 - $89.9 $5,433 - $8,630
96 Added 0.94%
10,296 $716,000
Q1 2022

Feb 14, 2023
BUY
$60.15 - $84.52 $613,530 - $862,104
10,200 New
10,200 $845,000
Q1 2022

May 13, 2022
BUY
$60.15 - $84.52 $613,530 - $862,104
10,200 New
10,200 $845,000
Q4 2021

Feb 14, 2022
SELL
$75.08 - $121.99 $412,940 - $670,945
-5,500 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$130.4 - $225.58 $1.47 Million - $2.55 Million
-11,300 Reduced 67.26%
5,500 $1.22 Million
Q1 2021

May 14, 2021
SELL
$124.11 - $190.17 $5.93 Million - $9.09 Million
-47,800 Reduced 73.99%
16,800 $2.22 Million
Q4 2020

Feb 12, 2021
BUY
$112.16 - $174.14 $2.65 Million - $4.11 Million
23,600 Added 57.56%
64,600 $11.2 Million
Q3 2020

Nov 13, 2020
BUY
$58.05 - $111.31 $1.85 Million - $3.54 Million
31,800 Added 345.65%
41,000 $4.56 Million
Q2 2020

Aug 14, 2020
SELL
$57.2 - $74.41 $1.05 Million - $1.36 Million
-18,300 Reduced 66.55%
9,200 $546,000
Q1 2020

May 15, 2020
SELL
$57.05 - $95.75 $1.6 Million - $2.68 Million
-28,000 Reduced 50.45%
27,500 $1.85 Million
Q4 2019

Feb 18, 2020
SELL
$68.3 - $93.8 $1.5 Million - $2.06 Million
-22,000 Reduced 28.39%
55,500 $4.68 Million
Q3 2019

Nov 14, 2019
BUY
$61.86 - $97.8 $909,342 - $1.44 Million
14,700 Added 23.41%
77,500 $5.8 Million
Q2 2019

Aug 13, 2019
SELL
$42.22 - $63.23 $194,212 - $290,858
-4,600 Reduced 6.82%
62,800 $3.97 Million
Q1 2019

May 14, 2019
BUY
$31.96 - $56.12 $671,160 - $1.18 Million
21,000 Added 45.26%
67,400 $3.25 Million
Q4 2018

Feb 13, 2019
BUY
$28.72 - $52.63 $875,960 - $1.61 Million
30,500 Added 191.82%
46,400 $1.55 Million
Q3 2018

Nov 08, 2018
SELL
$32.0 - $52.4 $278,400 - $455,880
-8,700 Reduced 35.37%
15,900 $833,000
Q1 2018

May 14, 2018
BUY
$19.3 - $23.65 $474,780 - $581,790
24,600 New
24,600 $536,000

Others Institutions Holding NVCR

# of Institutions
263
Shares Held
77M
Call Options Held
1.17M
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.37B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email